Ryman HealthcareRYHTY -12.82%70 10-Year RORE % is 0.00 as of Mar. 2025. GuruFocus rates RYHTY with a GF Score™ of 70/100. Among 321 Healthcare Providers & Services companies, Ryman Healthcare ranks worse than 87.54% on this metric.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Ryman Healthcare's 10-Year RORE % for the quarter that ended in Mar. 2025 was 0.00%.
The industry rank for Ryman Healthcare's 10-Year RORE % or its related term are showing as below:
RYHTY's 10-Year RORE % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 6.21 * Ranked among companies with meaningful 10-Year RORE % only.
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Ryman Healthcare 10-Year RORE % Related Terms
Ryman Healthcare 10-Year RORE % Historical Data
* Premium members only.
The historical data trend for Ryman Healthcare's 10-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Ryman Healthcare's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ryman Healthcare 10-Year RORE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ryman Healthcare's 10-Year RORE % distribution charts can be found below:
* The bar in red indicates where Ryman Healthcare's 10-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2025 and 10-year before.
Ryman Healthcare (RYHTY) has a 10-Year RORE % of 0.00 as of Mar. 2025. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on Ryman Healthcare and its competitors. According to the industry distribution chart, Ryman Healthcare ranks #281 out of 321 companies in the Healthcare Providers & Services industry, placing it in the top 87.5%.
Is Ryman Healthcare's 10-Year RORE % too high?
Ryman Healthcare's current 10-Year RORE % is 0.00. Based on the distribution chart, Ryman Healthcare ranks #281 out of 321 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Ryman Healthcare has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Ryman Healthcare's 10-Year RORE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ryman Healthcare ranks #281 out of 321 companies for 10-Year RORE %. This places Ryman Healthcare in the lower half of its industry. The industry median 10-Year RORE % is 6.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year RORE % for a Healthcare Providers & Services company?
The median 10-Year RORE % among Healthcare Providers & Services companies is 6.21, based on 321 companies in the industry. Companies in the top quartile (top 25%) have a 10-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 10-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year RORE % mean?
A high 10-Year RORE % can signal that a stock is expensive relative to its fundamentals. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on Ryman Healthcare and its competitors. For the Healthcare Providers & Services industry, the median 10-Year RORE % is 6.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ryman Healthcare's current 10-Year RORE % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ryman Healthcare stock overvalued right now?
Ryman Healthcare (RYHTY) has a current 10-Year RORE % of 0.00. The current 10-Year RORE % is 0.00. Ryman Healthcare's overall GF Score™ is 70/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year RORE % calculated?
10-Year RORE % is calculated from a company's financial statements. For Ryman Healthcare (RYHTY), the current 10-Year RORE % is 0.00 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ryman Healthcare Ltd is a retirement living and aged care provider operating in New Zealand and Australia. It owns and operates integrated retirement villages through its trading subsidiaries, which operate in the aged care and retirement living sector in New Zealand and Australia. The Group operates in a single industry: the provision of integrated retirement living and aged care for older people in New Zealand and Australia. The majority of revenue is derived from Care and village fees, which relate to the provision of accommodation, care and related services to aged care residents and retirement living residents.
70GF Score
Get the complete analysis for RYHTY
10-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RYHTY has been successfully added to your 
